- Home
- IRIX vs DRRX Comparison
IRIX vs DRRX Comparison
Compare IRIX & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRIX
- DRRX
- Stock Information
- Founded
- IRIX 1989
- DRRX 1998
- Country
- IRIX United States
- DRRX United States
- Employees
- IRIX N/A
- DRRX N/A
- Industry
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- IRIX Health Care
- DRRX Health Care
- Exchange
- IRIX Nasdaq
- DRRX Nasdaq
- Market Cap
- IRIX 28.6M
- DRRX 26.4M
- IPO Year
- IRIX 1996
- DRRX 2000
- Fundamental
- Price
- IRIX $1.69
- DRRX $0.84
- Analyst Decision
- IRIX Hold
- DRRX Buy
- Analyst Count
- IRIX 1
- DRRX 2
- Target Price
- IRIX $2.00
- DRRX $5.00
- AVG Volume (30 Days)
- IRIX 46.3K
- DRRX 117.8K
- Earning Date
- IRIX 11-12-2024
- DRRX 11-13-2024
- Dividend Yield
- IRIX N/A
- DRRX N/A
- EPS Growth
- IRIX N/A
- DRRX N/A
- EPS
- IRIX N/A
- DRRX N/A
- Revenue
- IRIX $48,431,000.00
- DRRX $8,594,000.00
- Revenue This Year
- IRIX N/A
- DRRX $54.32
- Revenue Next Year
- IRIX $5.44
- DRRX N/A
- P/E Ratio
- IRIX N/A
- DRRX N/A
- Revenue Growth
- IRIX N/A
- DRRX N/A
- 52 Week Low
- IRIX $1.27
- DRRX $0.68
- 52 Week High
- IRIX $3.65
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- IRIX 49.97
- DRRX 47.09
- Support Level
- IRIX $1.63
- DRRX $0.79
- Resistance Level
- IRIX $1.67
- DRRX $0.86
- Average True Range (ATR)
- IRIX 0.10
- DRRX 0.07
- MACD
- IRIX -0.00
- DRRX 0.01
- Stochastic Oscillator
- IRIX 37.93
- DRRX 78.39
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .